AHMED NADIM

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
11 9% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -20%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
AHMED NADIM's trades of Cullinan Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-25 2026-02-24
S Sale
93,661 -40.6%
165.88
US$2,561,023 		93,661 -40.6% 165.88 US$2,561,023
2026-02-23 2026-02-20
S Sale
43,690 -38.8%
20.87
US$1,894,405 		43,690 -38.8% 20.87 US$1,894,405
2025-12-29 2025-12-23
S Sale
69,233 -31.6%
210.05
US$3,214,322 		69,233 -31.6% 210.05 US$3,214,322
2025-02-27 2025-02-25
S Sale
12,529 -2.8%
8.53
US$106,872 		12,529 -2.8% 8.53 US$106,872
2024-12-27 2024-12-24
S Sale
8,400 -3.1%
11.87
US$99,708 		8,400 -3.1% 11.87 US$99,708
2023-12-27 2023-12-26
S Sale
4,272 -3.7%
9.24
US$39,473 		4,272 -3.7% 9.24 US$39,473
2023-06-29 2023-06-28
S Sale
759 -0.7%
11.40
US$8,653 		759 -0.7% 11.40 US$8,653
2023-05-24 2023-05-23
S Sale
707 -0.6%
9.15
US$6,469 		707 -0.6% 9.15 US$6,469
2023-04-26 2023-04-25
S Sale
716 -0.6%
10.59
US$7,582 		716 -0.6% 10.59 US$7,582
2023-03-27 2023-03-23
S Sale
706 -0.6%
10.51
US$7,420 		706 -0.6% 10.51 US$7,420
2022-06-07 2022-06-06
B Purchase
8,090 +inf%
12.40
US$100,316 		8,090 +inf% 12.40 US$100,316